Fair Value Calculator Fair Value Calculator
EN DE

1468 (1468) Fair Value & Analysis

Industrials · Market cap HK$24.2M

1 1468 1468 · HK
PriceHK$0.1970
Fair ValueHK$0.0748
Upside-62.0%
Quality30/100
Evidence: Low Range HK$0.0492 – HK$0.0936

Fair value as of: Jul 2, 2026

From 1 valuation models · updated today

Share price −35.4% over the past month.

Price vs Fair Value (12 months)

HK$1.43 HK$0.1970 Fair Value HK$0.0748 Jun 2025 Jun 2026

12‑month range HK$0.1970 – HK$1.43 · fair‑value band HK$0.0492 – HK$0.0936 · the HK$0.1970 price screens above the HK$0.0748 fair value. As of Jul 2, 2026.

✦ Which stocks are undervalued right now? Check free Discover now →

Analysis

1468 (1468) currently trades at HK$0.1970, while our model-based Fair Value estimate is HK$0.0748 — implying the stock looks roughly 62.0% overvalued today. We read business quality at 30/100 (below-average quality), in the Industrials sector. Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium — the entry price still matters most (evidence: low).

Trailing-twelve-month revenue stands at HK$98.7M. Revenue declined 60.4% year over year. It earns a return on equity of -16.4%. The balance sheet holds a net cash position of HK$74.8M. Fundamentals as of Jul 2, 2026

Key figures & financial health

Revenue (TTM) HK$98.7M
Revenue growth (YoY) -60.4%
Net margin -147%
Return on equity -16.4%
Free cash flow −HK$435M FY2025
Operating margin -313%
More key figures
EPS (TTM) HK$-0.1000
EPS growth (YoY) -92.9%
Net cash HK$74.8M FY2025

Figures from reported company fundamentals (EODHD) · as of Jul 2, 2026. TTM = trailing twelve months.

Revenue & earnings trend

FY2021 – FY2025 · reported fiscal years

1468 reported revenue of HK$228M in FY2025 versus HK$149M in FY2021, a compound +11.3%/yr. Reported net income was −HK$117M in FY2025.

Revenue +11.3%/yr
FY21 HK$149M
FY22 HK$127M
FY23 HK$331M
FY24 HK$330M
FY25 HK$228M
Net income
FY21 −HK$8.4M
FY22 −HK$73.1M
FY23 −HK$1.2B
FY24 −HK$551M
FY25 −HK$117M

Is 1468 fairly valued? → Check now

Similar stocks

6 more Conglomerates stocks, each showing price versus our Fair Value estimate (as of Jul 2, 2026).

Stock Price Fair Value vs Fair Value
Honeywell International Inc HON C$25.91 C$8.49 -67%
Hitachi, Ltd HTHIY $30.11 $31.31 +4%
CITIC Limited 0267 HK$13.62 HK$22.20 +63%
0019 0019 HK$81.70 HK$13.77 -83%
CK Hutchison Holdings 0001 HK$66.25 HK$118.82 +79%
SK Inc 034730 625,000 KRW 390,279 KRW -38%

Explore undervalued stocks

More undervalued Industrials stocks →

All undervalued stocks TechnologyFinancial ServicesHealthcareConsumer CyclicalConsumer DefensiveCommunication ServicesIndustrialsEnergyBasic MaterialsReal EstateUtilities Deeply Undervalued StocksUndervalued Blue-Chip StocksUndervalued Small-Cap Stocks

Frequently asked questions

Is 1468 (1468) undervalued?
As of Jul 2, 2026, our model estimates a fair value of HK$0.0748 versus a price of HK$0.1970 — about −62% (overvalued). Model-based estimate, not financial advice.
What is the fair value of 1468?
Our model-based fair value for 1468 is HK$0.0748 (as of Jul 2, 2026), built from audited fundamentals. The current price is HK$0.1970.
What is the quality score of 1468?
1468 has a Quality Score of 30/100, measuring profitability, growth and balance-sheet strength from non-valuation factors.
What is the revenue of 1468 (1468)?
1468 reported trailing-twelve-month revenue of about HK$98.7M (latest available figure, as of Jul 2, 2026).
What is the net profit margin of 1468?
The net profit margin of 1468 is about -147.4%, meaning it is currently running at a net loss. Based on the latest reported figures.

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.

Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.